Jens Olsson has sold shares in the biotechnology company Cyclezyme and fallen below the 5 percent flagging threshold. Olsson now owns 115,800 shares, which corresponds to 4.47 percent of the capital and voting rights. The holding previously amounted to 148,000 shares, corresponding to 5.71 percent of the capital and voting rights. This is stated in a flagging notification.